Bank of America’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.9K | Sell |
29,147
-5,559
| -16% | -$5.89K | ﹤0.01% | 5940 |
|
2025
Q1 | $37.8K | Sell |
34,706
-9,862
| -22% | -$10.8K | ﹤0.01% | 5803 |
|
2024
Q4 | $67.3K | Sell |
44,568
-76,202
| -63% | -$115K | ﹤0.01% | 5662 |
|
2024
Q3 | $180K | Sell |
120,770
-219,616
| -65% | -$327K | ﹤0.01% | 5204 |
|
2024
Q2 | $551K | Sell |
340,386
-1,027,529
| -75% | -$1.66M | ﹤0.01% | 4522 |
|
2024
Q1 | $2.33M | Sell |
1,367,915
-71,926
| -5% | -$122K | ﹤0.01% | 3638 |
|
2023
Q4 | $4.46M | Buy |
1,439,841
+1,290,912
| +867% | +$4M | ﹤0.01% | 3016 |
|
2023
Q3 | $914K | Sell |
148,929
-46,988
| -24% | -$289K | ﹤0.01% | 4082 |
|
2023
Q2 | $1.23M | Sell |
195,917
-735,781
| -79% | -$4.61M | ﹤0.01% | 3875 |
|
2023
Q1 | $4.44M | Sell |
931,698
-83,518
| -8% | -$398K | ﹤0.01% | 3104 |
|
2022
Q4 | $8.83M | Buy |
1,015,216
+540,845
| +114% | +$4.71M | ﹤0.01% | 2388 |
|
2022
Q3 | $5.65M | Buy |
474,371
+42,445
| +10% | +$505K | ﹤0.01% | 2719 |
|
2022
Q2 | $6.16M | Buy |
431,926
+175,089
| +68% | +$2.5M | ﹤0.01% | 2720 |
|
2022
Q1 | $5.35M | Buy |
256,837
+183,018
| +248% | +$3.81M | ﹤0.01% | 3069 |
|
2021
Q4 | $1.71M | Buy |
73,819
+46,850
| +174% | +$1.08M | ﹤0.01% | 4047 |
|
2021
Q3 | $804K | Sell |
26,969
-13,050
| -33% | -$389K | ﹤0.01% | 4516 |
|
2021
Q2 | $1.37M | Buy |
40,019
+1,273
| +3% | +$43.5K | ﹤0.01% | 4010 |
|
2021
Q1 | $1.27M | Buy |
38,746
+34,300
| +771% | +$1.13M | ﹤0.01% | 4075 |
|
2020
Q4 | $273K | Buy |
4,446
+4,146
| +1,382% | +$255K | ﹤0.01% | 4689 |
|
2020
Q3 | $11K | Buy |
+300
| New | +$11K | ﹤0.01% | 5764 |
|